Day 3 Highlights | ESC Congress 2019 #cardiology

Day 3 Highlights | ESC Congress 2019 #cardiology

Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease (AFIRE—0:35); effects of sacubitril-valsartan compared with enalapril on arterial hemodynamics and cardiac remodeling in patients with heart failure and reduced ejection fraction (EVALUATE-HF, PROVE-HF—4:39); using cardiolinguistics and artificial intelligence to reframe typical and atypical angina (HERMES—4:45); and the combined effect of lower LDL-C and lower systolic blood pressure on the lifetime risk of cardiovascular disease (LDL SBP—6:15). Visit https://www.acc.org/esc2019 for full meeting coverage.

source

Leave a Reply

Your email address will not be published.